Skip to main content
Caplight Logo









Clover Biopharmaceuticals

Clover Biopharmaceuticals

Public
Shanghai, ShanghaiBiotechhttps://www.cloverbiopharma.com

Clover Biopharmaceuticals is now publicly traded

The data on this page reflects Clover Biopharmaceuticals's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Follow-on Offering

Apr 29, 2026

Total Funding Raised

$3.64M

Company Overview

Clover Biopharmaceuticals (HKG: 02197) is a biotechnology company focused on creating innovative vaccines and biologic therapies for infectious diseases, cancer, and autoimmune disorders.

Sector

Biotech

AI Layer

Non-AI

Keywords

Trimer-Tag technology platformprotein-based subunit vaccinesinfectious disease vaccine developmentrespiratory vaccinesCOVID-19 vaccineRSV vaccine candidategovernment vaccine supply agreementsin-house GMP biomanufacturingcovalently-trimerized fusion proteinsquadrivalent seasonal influenza vaccineCOVAX facility vaccine supplierthrombopoietin receptor agonist

Clover Biopharmaceuticals Comparables

Compare Clover Biopharmaceuticals with similar companies based on industry and business-model similarity.

Clover Biopharmaceuticals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Clover Biopharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Follow-on OfferingApr 29, 2026
View all Funding Rounds

Clover Biopharmaceuticals Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Clover Biopharmaceuticals Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersShanghai, Shanghai
Employee Range158
Year Founded2007
Last FundingApr 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?